Invention Grant
- Patent Title: Compounds
- Patent Title (中): 化合物
-
Application No.: US13414873Application Date: 2012-03-08
-
Publication No.: US08993560B2Publication Date: 2015-03-31
- Inventor: Francis Louis Atkinson , Michael David Barker , John Liddle , David Matthew Wilson
- Applicant: Francis Louis Atkinson , Michael David Barker , John Liddle , David Matthew Wilson
- Applicant Address: GB Brentford, Middlesex
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Duke M. Fitch; John Lemanowicz; William R. Majarian
- Priority: GB1104153.0 20110311
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D401/12 ; C07D403/12 ; A61K31/4725 ; A61K45/06 ; C07D401/14

Abstract:
A compound of formula (I): or a salt thereof; which is an inhibitor of spleen tyrosine kinase (SYK) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory diseases and/or allergic conditions, in cancer therapy, specifically heme malignancies, and autoimmune conditions.
Public/Granted literature
- US20120232061A1 NOVEL COMPOUNDS Public/Granted day:2012-09-13
Information query